Results of clinical trial in Russia to assess immunological efficacy and safety of meningococcal vaccine (serogroups A, C, Y, W, X) in adults
Relevance. The diverse serogroup composition of meningococcal pathogens circulating in different countries, the challenges in predicting serogroup prevalence, migration processes, and the active aerosol transmission mechanism of meningococcal infection necessitate the use of vaccines with the broade...
Saved in:
| Main Authors: | I. V. Fel'dblyum, S. O. Golodnova, M. Kh. Alyeva, T. M. Repin, E. V. Gorelikova, A. S. Korovkin, E. S. Safonova, A. M. Vlasov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2025-07-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/2252 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01) -
Genomic analysis of Neisseria meningitidis serogroup W causing invasive meningococcal disease in four travellers from Saudi Arabia, Italy, 2025
by: Paola Stefanelli
Published: (2025-08-01) -
Outbreak of Neisseria meningitidis serogroup B in Aragón, Spain, January to February 2025
by: Maria Carmen Montaño Remacha
Published: (2025-04-01) -
Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review
by: Steven Shen, et al.
Published: (2024-11-01) -
Genetically distinct Hajj and South American-related strains of serogroup W Neisseria meningitidis causing invasive meningococcal disease in Ontario, Canada, January 1, 2015 to June 30, 2024
by: Courtney Meilleur, et al.
Published: (2025-05-01)